Evaluation of Hepatitis B Reactivation Among Patients With Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors

Hepatitis B reactivation (HBVr) in cancer patients is a well-established complication due to chemotherapy-induced immunosuppression. Studies have reported HBVr associated with immunosuppressive medications, such as rituximab, methotrexate, and high dose steroids. There are different risks for differ...

Descripción completa

Detalles Bibliográficos
Autores principales: Atteya, Asmaa, Ahmad, Aiman, Daghstani, Dima, Mushtaq, Kamran, Yassin, Mohamed A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8480343/
https://www.ncbi.nlm.nih.gov/pubmed/33297765
http://dx.doi.org/10.1177/1073274820976594

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8480343/
https://www.ncbi.nlm.nih.gov/pubmed/33297765
http://dx.doi.org/10.1177/1073274820976594

Ejemplares similares